Discovery of a highly potent FLT3 kinase inhibitor for FLT3-ITD-positive AML.
about
A novel t(3;13)(q13;q12) translocation fusing FLT3 with GOLGB1: toward myeloid/lymphoid neoplasms with eosinophilia and rearrangement of FLT3?DNMT3A co-mutation is required for FLT3-ITD as an adverse prognostic indicator in intermediate-risk cytogenetic group AML.Rational Design, Synthesis and Biological Evaluation of Pyrimidine-4,6-diamine derivatives as Type-II inhibitors of FLT3 Selective Against c-KIT.
P2860
Discovery of a highly potent FLT3 kinase inhibitor for FLT3-ITD-positive AML.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Discovery of a highly potent FLT3 kinase inhibitor for FLT3-ITD-positive AML.
@en
type
label
Discovery of a highly potent FLT3 kinase inhibitor for FLT3-ITD-positive AML.
@en
prefLabel
Discovery of a highly potent FLT3 kinase inhibitor for FLT3-ITD-positive AML.
@en
P2093
P2860
P356
P1433
P1476
Discovery of a highly potent FLT3 kinase inhibitor for FLT3-ITD-positive AML.
@en
P2093
A Christodoulou
D Weinstock
E L Weisberg
I A Galinsky
P2860
P2888
P304
P356
10.1038/LEU.2016.151
P577
2016-05-25T00:00:00Z
P6179
1028958433